Skip to main content
. Author manuscript; available in PMC: 2017 Jan 29.
Published in final edited form as: Pigment Cell Melanoma Res. 2016 Jan 29;29(2):176–185. doi: 10.1111/pcmr.12437

Table 2.

Survival results of 18 tag SNPs (r-square >0.6) with FPRP < 0.2 in the MDACC dataset and their replication in the Harvard dataset.

SNP Gene Chr EA MDACC
Harvard
Meta
MAF HR (95%CI) P* FPRP MAF HR (95%CI) P** HR(95%CI) P I2 Phet
rs6426914 RXRG 1 G 0.06 2.04 (1.18 – 3.53) 1.10×10−2 0.171 0.06 0.82 (0.32–2.07) 0.669 1.40 (0.58 – 3.30) 0.453 63.60 0.099
rs283695 RXRG 1 A 0.45 1.68 (1.24 – 2.29) 9.00×10−4 0.011 0.44 0.87 (0.57–1.31) 0.492 1.23 (0.65 – 2.34) 0.534 84.18 0.013
rs285480 RXRG 1 G 0.22 1.47 (1.06 – 2.04) 2.05×10−2 0.165 0.22 1.14 (0.72–1.80) 0.581 1.35 (1.03 – 1.76) 0.027 0.00 0.376
rs3767332 RXRG 1 A 0.24 0.59 (0.39 – 0.89) 1.10×10−2 0.120 0.24 0.91 (0.57–1.46) 0.687 0.72 (0.47 – 1.10) 0.127 46.23 0.175
rs157861 RXRG 1 G 0.21 1.51 (1.09 – 2.08) 1.23×10−2 0.099 0.19 0.97 (0.59–1.60) 0.914 1.26 (0.83 – 1.93) 0.285 53.64 0.144
rs115079560 RXRG 1 C 0.16 1.65 (1.18 – 2.30) 3.08×10−3 0.031 0.14 0.87 (0.48–1.58) 0.654 1.26 (0.68 – 2.34) 0.467 70.55 0.066
rs3753896 RXRG 1 G 0.38 1.58 (1.15 – 2.15) 4.35×10−3 0.034 0.35 0.88 (0.57–1.34) 0.541 1.20 (0.68 – 2.13) 0.531 78.92 0.030
rs3820367 RXRG 1 G 0.21 1.51 (1.11 – 2.04) 7.95×10−3 0.063 0.21 0.87 (0.52–1.46) 0.597 1.19 (0.70 – 2.04) 0.514 69.19 0.071
rs2194899 RXRG 1 A 0.37 1.51 (1.13 – 2.01) 5.18×10−3 0.042 0.34 0.72 (0.46–1.14) 0.159 1.07 (0.52 – 2.20) 0.863 86.20 0.007
rs3753898 RXRG 1 G 0.21 1.44 (1.06 – 1.95) 1.84×10−2 0.144 0.20 0.84 (0.49–1.43) 0.515 1.15 (0.69 – 1.94) 0.593 66.11 0.086
rs1529382 CYP27A1 2 T 0.49 1.70 (1.26 – 2.31) 6.00×10−4 0.007 0.50 1.25 (0.83–1.89) 0.282 1.50 (1.12 – 2.02) 0.007 28.86 0.238
rs12512631 VDBP 4 C 0.36 0.70 (0.51 – 0.95) 2.41×10−2 0.168 0.35 0.58 (0.36–0.93) 0.025 0.66 (0.51 – 0.86) 1.88×10−3 0.00 0.516
rs7850212 RXRA 9 A 0.11 0.41 (0.21 – 0.78) 7.15×10−3 0.179 0.09 0.31 (0.10–0.97) 0.043 0.38 (0.22 – 0.68) 9.54×10−4 0.00 0.676
rs67965144 RXRA 9 A 0.12 1.52 (1.07 – 2.16) 2.04×10−2 0.158 0.13 0.79 (0.43–1.48) 0.469 1.15 (0.61 – 2.17) 0.656 68.86 0.071
rs62576319 RXRA 9 T 0.11 1.71 (1.17 – 2.49) 5.12×10−3 0.055 0.12 1.00 (0.55–1.82) 0.992 1.38 (0.82 – 2.31) 0.222 54.59 0.137
rs12895681 SNW1 14 T 0.32 1.42 (1.06 – 1.90) 1.81×10−2 0.142 0.35 0.92 (0.59–1.43) 0.719 1.18 (0.78 – 1.80) 0.439 61.72 0.109
rs12890375 SNW1 14 G 0.26 0.66 (0.45 – 0.95) 2.45×10−2 0.197 0.27 1.10 (0.71–1.72) 0.664 0.84 (0.51 – 1.39) 0.490 66.68 0.084
rs77513685 NCOA3 20 T 0.21 1.50 (1.07 – 2.12) 2.01×10−2 0.170 0.21 1.52 (0.98–2.35) 0.061 1.51 (1.15 – 1.97) 0.003 0.00 0.963

EA = effect allele; MAF=minor allele frequency; HR = hazards ratio; LHR = lower hazards ratio; UHR = upper hazards ratio; FPRP = false positive report probability; Phet = P heterogeniety;

A2 is the effect allele;

*

Adjusted by age, sex, tumor stage, Breslow thickness, Clark level and ulceration of tumor;

**

Adjusted by age, sex.